Product Description
Product Name: Lenvima
Generic Name: Lenvatinib Capsules
Strength: 10 mg
Form: Oral Capsule
Category: Antineoplastic / Tyrosine Kinase Inhibitor (TKI)
Indication: Advanced and Metastatic Cancers
Lenvima (Lenvatinib) 10 mg Capsule is a targeted oral cancer therapy classified as a multi-kinase inhibitor. It is used in the treatment of advanced or metastatic cancers by inhibiting multiple receptor tyrosine kinases involved in tumor growth and angiogenesis.
